Wyeth v. Diana Levine
Product Liability, Prescription Drugs, Drug Labeling, Administrative Law, Federal Food, Drug, and Cosmetic Act
Whether the prescription drug labeling judgments imposed on manufacturers by the Food and Drug Administration ("FDA") pursuant to FDA's comprehensive safety and efficacy authority under the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. section 301 et seq., preempt state law product liability claims premised on the theory that different labeling judgments were necessary to make drugs reasonably safe for use.
To view PDF files listed on this page you will need Adobe Acrobat Reader